Stonebridge Capital Advisors LLC Organon & Co. Transaction History

Stonebridge Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$16.59 - $23.77 $912 - $1,307	55 Added 7.37%	801 $13,000
Q2 2023 Aug 23, 2023	SELL	$19.27 - $24.63 $443 - $566	-23 Reduced 2.99%	746 $15,000
Q1 2023 May 12, 2023	SELL	$21.42 - $32.08 $1,006 - $1,507	-47 Reduced 5.76%	769 $18,000
Q4 2022 Feb 14, 2023	SELL	$23.31 - $28.61 $885 - $1,087	-38 Reduced 4.45%	816 $22,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $210 - $308	-9 Reduced 1.04%	854 $20,000
Q2 2022 Aug 12, 2022	SELL	$31.66 - $38.9 $474 - $583	-15 Reduced 1.71%	863 $29,000
Q1 2022 May 13, 2022	SELL	$30.45 - $39.36 $288,148 - $372,463	-9,463 Reduced 91.51%	878 $31,000
Q4 2021 Feb 14, 2022	SELL	$28.67 - $37.13 $13,073 - $16,931	-456 Reduced 4.22%	10,341 $315,000
Q3 2021 Nov 15, 2021	SELL	$28.63 - $35.64 $4,094 - $5,096	-143 Reduced 1.31%	10,797 $354,000
Q2 2021 Aug 20, 2021	BUY	$28.45 - $38.0 $311,243 - $415,720	10,940 New	10,940 $331,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Stonebridge Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Stonebridge Capital Advisors LLC with notifications on news.